Definitions of asthma exacerbations

Current Opinion in Allergy and Clinical Immunology

Volumn 11, Issue 3, 2011, Pages 181-186

  Loymans, Rik J B ^a   Ter Riet, Gerben ^a   Sterk, Peter J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

asthma exacerbation; definition; outcome measures; prevalence

Indexed keywords

CORTICOSTEROID;

ASTHMA; ASTHMA EXACERBATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DECISION MAKING; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; HUMAN; INCIDENCE; MEDICAL RESEARCH; MORTALITY; PATIENT IDENTIFICATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ASTHMA; BIOLOGICAL MARKERS; CLINICAL TRIALS AS TOPIC; DISEASE PROGRESSION; HUMANS; INCIDENCE; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC;

EID: 79955575383     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e3283466f45     Document Type: Review

References (48)

1. GINA. Global strategy for asthma management and prevention. 2009. www.ginasthma.com. [Accessed 4 January 2011].
2. Papadopoulos NG, Christodoulou I, Rohde G, et al. Viruses and bacteria inacute asthma exacerbations: a GA(2) LEN-DARE systematic review. Allergy 2011; 66:458-468 doi: 10.1111/j.1398-9995.2010.02505.x.
3. May L, Carim M, Yadav K. Adult asthma exacerbations and environmental triggers: a retrospective review of ED visits using an electronic medical record. Am J Emerg Med 2010 doi:10.1016/j.ajem.2010.06.034.
4. Lloyd A, Price D, Brown R. The impact of asthma exacerbations on healthrelated quality of life in moderate to severe asthma patients in the UK. Prim Care Respir J 2007; 16:22-27. (Pubitemid 46364352)
5. Asthma prevalence, healthcare use and mortality. United States, 2003-05. NCHS Health E-Stat 2011 http://www.cdc.gov/nchs/data/hestat/asthma03- 05/asthma03-05.htm. [Accessed 4 January 2011].
6. Bavbek S, Mungan D, Turktas H, et al. A cost-of-illness study estimating the direct cost per asthma exacerbation in Turkey. Respir Med 2011; 105:541-548.
7. Lane S, Molina J, Plusa T. An international observational prospective study to determine the cost of asthma exacerbations (COAX). Respir Med 2006; 100:434-450. (Pubitemid 43239877)
8. O'Byrne PM, Pedersen S, Lamm CJ, et al. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med 2009; 179:19-24.
9. NAEPP. Expert Panel Report 3: guidelines for the diagnosis and management of asthma. 2007. http://www.nhlbi.nih.gov/guidelines/asthma/. [Accessed 4 January 2011].
10. van der Molen T, Ostrem A, Stallberg B, et al. International Primary Care Respiratory Group (IPCRG) guidelines: management of asthma. Prim Care Respir J 2006; 15:35-47. (Pubitemid 43158388)
11. Wijesinghe M, Weatherall M, Perrin K, et al. International trends in asthma mortality rates in the 5- to 34-year age group: a call for closer surveillance. Chest 2009; 135:1045-1049. This study reveals the worldwide decrease of mortality due to asthma exacerbations.
12. Rowe BH, Voaklander DC, Wang D, et al. Asthma presentations by adults to emergency departments in Alberta, Canada: a large population-based study. Chest 2009; 135:57-65.
13. Lougheed MD, Garvey N, Chapman KR, et al. Variations and gaps in management of acute asthma in Ontario emergency departments. Chest 2009; 135:724-736.
14. Oborne J, Mortimer K, Hubbard RB, et al. Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial. Am J Respir Crit Care Med 2009; 180:598-602.
15. Partridge MR. What do the words 'asthma control' and 'exacerbation' really mean? Prim Care Respir J 2004; 13:179-180. (Pubitemid 39536033)
16. Taylor DR, Bateman ED, Boulet LP, et al. A new perspective on concepts of asthma severity and control. Eur Respir J 2008; 32:545-554.
17. Castro M, Rubin AS, Laviolette M, et al. Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med 2010; 181:116-124.
18. Corren J, Busse W, Meltzer EO, et al. A randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma. Am J Respir Crit Care Med 2010; 181:788-796.
19. Ducharme FM, Ni CM, Greenstone I, Lasserson TJ. Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev 2010; CD005535.
20. Frois C, Wu EQ, Ray S, Colice GL. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol. Clin Ther 2009; 31:2779-2803.
21. Murphy VE, Clifton VL, Gibson PG. The effect of cigarette smoking on asthma control during exacerbations in pregnant women. Thorax 2010; 65:739-744.
22. O'Connor RD, Bleecker ER, Long A, et al. Subacute lack of asthma control and acute asthma exacerbation history as predictors of subsequent acute asthma exacerbations: evidence from managed care data. J Asthma 2010; 47:422-428.
23. Patel YA, Patel P, Bavadia H, et al. A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting beta2 agonist in the treatment of moderate-to-severe persistent asthma. J Postgrad Med 2010; 56:270-274.
24. Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010; 363:1715-1726.
25. Price D, Martin RJ, Barnes N, et al. Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study. J Allergy Clin Immunol 2010; 126:511-518.
26. Renzi PM, Howard LA, Ortega HG, et al. Low-dose fluticasone propionate with and without salmeterol in steroid-naive patients with mild, uncontrolled asthma. Respir Med 2010; 104:510-517.
27. Leidy NK, Wilcox TK, Jones PW, et al. Standardizing measurement of chronic obstructive pulmonary disease exacerbations: reliability and validity of a patient-reported diary. Am J Respir Crit Care Med 2011; 183:323-329.
28. Effing TW, Kerstjens HA, Monninkhof EM, et al. Definitions of exacerbations: does it really matter in clinical trials on COPD? Chest 2009; 136:918-923.
29. Calverley P, Pauwels DR, Lofdahl CG, et al. Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur Respir J 2005; 26:406-413. (Pubitemid 41264201)
30. Toy EL, Gallagher KF, Stanley EL, et al. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD 2010; 7:214-228.
31. O'Reilly JF, Williams AE, Holt K, Rice L. Defining COPD exacerbations: impact on estimation of incidence and burden in primary care. Prim Care Respir J 2006; 15:346-353. (Pubitemid 44810150)
32. Reddel HK, Taylor DR, Bateman ED, et al. An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med 2009; 180:59-99.
33. Bousquet J, Mantzouranis E, Cruz AA, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010; 126:926-938.
34. Fitzgerald JM, O'Byrne PM, McFetridge JT, et al. Pulmonary function testing in the emergency department and medications prescribed at discharge: results of the Multinational Acute asthma Management, Burden, and Outcomes (MAMBO) study. Prim Care Respir J 2010; 19:155-162.
35. Reddel H, Ware S, Marks G, et al. Differences between asthma exacerbations and poor asthma control. Lancet 1999; 353:364-369. (Pubitemid 29088164)
36. Tattersfield AE, Postma DS, Barnes PJ, et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med 1999; 160:594-599. (Pubitemid 29380678)
37. Rodrigo GJ, Rodrigo C, Hall JB. Acute asthma in adults: a review. Chest 2004; 125:1081-1102. (Pubitemid 38367305)
38. van den Nieuwenhof L, Schermer T, Heins M, et al. Tracing uncontrolled asthma in family practice using a mailed asthma control questionnaire. Ann Fam Med 2008; 6 (Suppl 1):S16-S22.
39. Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying 'well controlled' and 'not well controlled' asthma using the Asthma Control Questionnaire. Respir Med 2006; 100:616-621. (Pubitemid 43285748)
40. O'Byrne PM, Reddel HK, Eriksson G, et al. Measuring asthma control: a comparison of three classification systems. Eur Respir J 2010; 36:269-276.
41. Frey U, Brodbeck T, Majumdar A, et al. Risk of severe asthma episodes predicted from fluctuation analysis of airway function. Nature 2005; 438:667-670. (Pubitemid 41740576)
42. Jatakanon A, Lim S, Barnes PJ. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000; 161:64-72. (Pubitemid 30055904)
43. Leuppi JD, Salome CM, Jenkins CR, et al. Predictive markers of asthma exacerbation during stepwise dose reduction of inhaled corticosteroids. Am J Respir Crit Care Med 2001; 163:406-412. (Pubitemid 32158520)
44. Zacharasiewicz A, Wilson N, Lex C, E et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med 2005; 171:1077-1082. (Pubitemid 40663717)
45. Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360:1715-1721. (Pubitemid 35447900)
46. Jayaram L, Pizzichini MM, Cook RJ, et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006; 27:483-494. (Pubitemid 43372521)
47. Kato M, Yamada Y, Maruyama K, Hayashi Y. Serum eosinophil cationic protein and 27 cytokines/chemokines in acute exacerbation of childhood asthma. Int Arch Allergy Immunol 2010; 152 (Suppl 1):62-66.
48. Petsky HL, Cates CJ, Lasserson TJ, et al. A systematic review and metaanalysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2010 doi: 10.1136/thx.2010.135574.